American Diabetes Association Research Foundation Inc: Form 990, tax year 2021
View the entire original 990 at ProPublica ↗
- Organization
- American Diabetes Association Research Foundation Inc (EIN 54-1734511)
- Tax period
- 2021-01-01 to 2021-12-31
- Filed
- 2022-10-06
- IRS object ID
- 202212799349300416
- Schema version
- 2021v4.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule I
- Schedule J
- Schedule L
- Schedule N
- Schedule O
- Schedule R
- Affiliate Listing
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2022-10-06T09:28:22-00:00 | ReturnTs |
| Tax Period End | 2021-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 135381590 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | BDO USA LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 8401 Greensboro Drive Suite 800 | AddressLine1Txt |
| City | McLean | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22102 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2021-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 541734511 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | American Diabetes Association Research Foundation Inc | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | AMER | BusinessNameControlTxt |
| Phone | 7035491500 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2451 Crystal Drive Suite 900 | AddressLine1Txt |
| City | Arlington | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22202 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | Charlotte M Carter | PersonNm |
| Person Title | Chief Financial Officer | PersonTitleTxt |
| Phone | 7035491500 | PhoneNum |
| Signature | 2022-10-06 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | Charlotte | PersonFirstNm |
| Person Last | Carter | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | XXX-XX-XXXX | SSN |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | Marc Berger | PreparerPersonNm |
| PTIN | P01871563 | PTIN |
| Phone | 7038930600 | PhoneNum |
| Preparation | 2022-10-06 | PreparationDt |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 2 | TrustedCustomerCd |
| Authentication Assurance Level | AAL1 | AuthenticationAssuranceLevelCd |
| Identity Assurance Level | IAL1 | IdentityAssuranceLevelCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2021 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Final Return | Yes (X) | FinalReturnInd |
| Principal Officer | Charles D Henderson | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2451 Crystal Dr Suite 900 | AddressLine1Txt |
| City | Arlington | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22202 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $9,794,159 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Group Exemption | 3326 | GroupExemptionNum |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | www.diabetes.org/news-research | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1994 | FormationYr |
| Legal Domicile State | VA | LegalDomicileStateCd |
| Activity Or Mission | The American Diabetes Association Research Foundation, Inc. the Foundation secures major gifts and grants to fund diabetes-related research. Please see complete mission statement in Schedule O | ActivityOrMissionDesc |
| Contract Termination | Yes (X) | ContractTerminationInd |
| Voting Members Governing Body | 9 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 9 | VotingMembersIndependentCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Total Volunteers | 63 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| PY Contributions Grants | $9,866,077 | PYContributionsGrantsAmt |
| CY Contributions Grants | $9,787,622 | CYContributionsGrantsAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| CY Investment Income | $6,537 | CYInvestmentIncomeAmt |
| CY Other Revenue | $0 | CYOtherRevenueAmt |
| PY Total Revenue | $9,866,077 | PYTotalRevenueAmt |
| CY Total Revenue | $9,794,159 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $16,064,785 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $16,216,251 | CYGrantsAndSimilarPaidAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| CY Salaries Comp Emp Bnft Paid | $0 | CYSalariesCompEmpBnftPaidAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $451,756 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $517,290 | PYOtherExpensesAmt |
| CY Other Expenses | $722,809 | CYOtherExpensesAmt |
| PY Total Expenses | $16,582,075 | PYTotalExpensesAmt |
| CY Total Expenses | $16,939,060 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$6,715,998 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$7,144,901 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $18,545,687 | TotalAssetsBOYAmt |
| Total Assets EOY | $0 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $3,575,966 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $0 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $14,969,721 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $0 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | The Foundation was founded to give focus to the American Diabetes Associations research program and to ensure the availability of funds to support research. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | Yes (true) | SignificantChangeInd |
| Expense | $16,216,251 | ExpenseAmt |
| Grant | $16,216,251 | GrantAmt |
| Desc | Research Continued on Sch. O | Desc |
| Total Program Service Expenses | $16,216,251 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | false | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | false | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | false | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | false | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (true) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | false | ForeignOfficeInd |
| Foreign Activities | false | ForeignActivitiesInd |
| More Than5000 K To Org | false | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | false | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | Yes (true) | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | Yes (true) | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | false | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | false | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | Yes (true) | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | false | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | Yes (true) | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 0 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Employee | 0 | EmployeeCnt |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | false | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | false | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 9 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 9 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (true) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | Yes (true) | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | Yes (true) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (true) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | false | CompensationProcessCEOInd |
| Compensation Process Other | false | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AZ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | DC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | LA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | Charlotte M Carter CFO | PersonNm |
| Phone | 7035491500 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2451 Crystal Drive Suite 900 | AddressLine1Txt |
| City | Arlington | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22202 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part VII | Yes (X) | InfoInScheduleOPartVIIInd |
Form990 Part VII Section A Form990PartVIISectionAGrp (30 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd |
|---|---|---|---|---|---|---|---|
| Tracey D Brown through October 6 20 | |||||||
| Chief Executive Officer | 000.10 | 037.40 | Yes (X) | $0 | $1,047,921 | $138,575 | |
| Robert A Gabbay | |||||||
| Chief Scientific Medical Officer and Office of the CEO | 000.10 | 037.40 | Yes (X) | $0 | $457,210 | $42,390 | |
| Charlotte M Carter | |||||||
| Chief Financial Officer and Office of the CEO | 000.10 | 037.40 | Yes (X) | $0 | $324,015 | $29,537 | |
| Charles D Henderson | |||||||
| Chief Development Officer and Office of the CEO | 000.10 | 037.40 | Yes (X) | $0 | $294,338 | $16,308 | |
| Karen Talmadge PhD through October | |||||||
| Vice Chair of the Board | 000.10 | Yes (X) | $0 | $0 | $0 | Yes (X) | |
| Pearson C Cummin III MBA through Oc | |||||||
| Secretary-Treasurer | 000.10 | Yes (X) | $0 | $0 | $0 | Yes (X) | |
| Ruth Weinstock effective October 25 | |||||||
| Chair of the Board | 000.10 | 006.20 | Yes (X) | $0 | $0 | $0 | Yes (X) |
| Matthew Rifkin through October 25 2 | |||||||
| Board of Directors | 000.10 | $0 | $0 | $0 | Yes (X) | ||
| Tim Erblich through October 25 2021 | |||||||
| Board of Directors | 000.10 | $0 | $0 | $0 | Yes (X) | ||
| George J Huntley CPA through Octobe | |||||||
| Board of Directors | 000.10 | $0 | $0 | $0 | Yes (X) | ||
| James A Horbowicz through October 2 | |||||||
| Board of Directors | 000.10 | $0 | $0 | $0 | Yes (X) | ||
| Alan Altschuler through October 25 | |||||||
| Board of Directors | 000.10 | $0 | $0 | $0 | Yes (X) | ||
| Al Powers through October 25 2021 | |||||||
| Board of Directors | 000.10 | $0 | $0 | $0 | Yes (X) | ||
| Edward T Hawthorne through October | |||||||
| Board of Directors | 000.10 | $0 | $0 | $0 | Yes (X) | ||
| John W Griffin Jr JD through Octobe | |||||||
| Board of Directors | 000.10 | $0 | $0 | $0 | Yes (X) | ||
| Umesh Verma | |||||||
| Board of Directors | 000.10 | 001.00 | $0 | $0 | $0 | Yes (X) | |
| Orville G Kolterman MD through Octo | |||||||
| Board of Directors | 000.10 | $0 | $0 | $0 | Yes (X) | ||
| Linda Cummin through October 25 202 | |||||||
| Board of Directors | 000.10 | $0 | $0 | $0 | Yes (X) | ||
| Desmond Schatz MD through October 2 | |||||||
| Board of Directors | 000.10 | $0 | $0 | $0 | Yes (X) | ||
| John E Anderson MD through October | |||||||
| Board of Directors | 000.10 | $0 | $0 | $0 | Yes (X) | ||
| Geralyn R Spollet MSN ANP-CS CDE th | |||||||
| Board of Directors | 000.10 | $0 | $0 | $0 | Yes (X) | ||
| James W Quinn JD through October 25 | |||||||
| Board of Directors | 000.10 | $0 | $0 | $0 | Yes (X) | ||
| Donald J Wagner through October 25 | |||||||
| Board of Directors | 000.10 | $0 | $0 | $0 | Yes (X) | ||
| Martha Parry Clark effective Octobe | |||||||
| Board of Directors | 000.10 | 001.00 | $0 | $0 | $0 | Yes (X) | |
| Guillermo Umpierrez effective Octob | |||||||
| Board of Directors | 000.10 | 002.20 | $0 | $0 | $0 | Yes (X) | |
| Cynthia E Munoz effective October 2 | |||||||
| Board of Directors | 000.10 | 006.20 | $0 | $0 | $0 | Yes (X) | |
| Stephanie Silverman effective Octob | |||||||
| Board of Directors | 000.10 | 001.00 | $0 | $0 | $0 | Yes (X) | |
| Amparo Gonzalez effective October 2 | |||||||
| Board of Directors | 000.10 | 001.00 | $0 | $0 | $0 | Yes (X) | |
| Rone Luczynski effective October 25 | |||||||
| Board of Directors | 000.10 | 001.00 | $0 | $0 | $0 | Yes (X) | |
| Mary de Groot effective October 25 | |||||||
| Board of Directors | 000.10 | 001.00 | $0 | $0 | $0 | Yes (X) | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tot Reportable Comp Rltd Org | $2,123,484 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $226,810 | TotalOtherCompensationAmt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp
Contractor Name ContractorName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | NA | PersonNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Federated Campaigns | $73,488 | FederatedCampaignsAmt |
| Related Organizations | $6,220,482 | RelatedOrganizationsAmt |
| All Other Contributions | $3,493,652 | AllOtherContributionsAmt |
| Total Contributions | $9,787,622 | TotalContributionsAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $6,537 | TotalRevenueColumnAmt |
| Exclusion | $6,537 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $9,794,159 | TotalRevenueColumnAmt |
| Exclusion | $6,537 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $16,198,251 | TotalAmt |
| Program Services | $16,198,251 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $18,000 | TotalAmt |
| Program Services | $18,000 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $722,809 | TotalAmt |
| Management And General | $271,053 | ManagementAndGeneralAmt |
| Fundraising | $451,756 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fees For Services Prof Fundraising | FeesForServicesProfFundraising |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $16,939,060 | TotalAmt |
| Program Services | $16,216,251 | ProgramServicesAmt |
| Management And General | $271,053 | ManagementAndGeneralAmt |
| Fundraising | $451,756 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $270,594 | BOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $18,179,378 | BOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $95,715 | BOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $18,545,687 | BOYAmt |
| EOY | $0 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,575,966 | BOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,575,966 | BOYAmt |
| EOY | $0 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $14,969,721 | BOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $14,969,721 | BOYAmt |
| EOY | $0 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $18,545,687 | BOYAmt |
| EOY | $0 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | -$7,144,901 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $6,237 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | -$7,831,057 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consol And Sep Basis Fincl Stmt | Yes (X) | ConsolAndSepBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | false | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $35,119,963 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $16,438,956 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $20,934,789 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $9,866,077 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $9,787,622 | CurrentTaxYearAmt |
| Total | $92,147,407 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $35,119,963 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $16,438,956 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $20,934,789 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $9,866,077 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $9,787,622 | CurrentTaxYearAmt |
| Total | $92,147,407 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support Total170 | $92,147,407 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $3,514 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $4,009 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $7,816 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year | $6,537 | CurrentTaxYearAmt |
| Total | $21,876 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $92,169,283 | TotalSupportAmt |
| Public Support CY170 | 0.99980 | PublicSupportCY170Pct |
| Public Support PY170 | 0.99980 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Incl Escrow Custodial Acct Liab | false | InclEscrowCustodialAcctLiabInd |
Other Securities OtherSecuritiesGrp (2 entries)
| DescDesc |
|---|
| Financial derivatives and other financial products |
| Closely-held equity interests |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | Federal income taxes | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $9,824,810 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $6,237 | NetUnrealizedGainsInvstAmt |
| Donated Services And Use Fclts | $24,414 | DonatedServicesAndUseFcltsAmt |
| Revenue Not Reported | $30,651 | RevenueNotReportedAmt |
| Revenue Subtotal | $9,794,159 | RevenueSubtotalAmt |
| Total Revenue Per Form990 | $9,794,159 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $16,390,736 | TotExpnsEtcAuditedFinclStmtAmt |
| Donated Services Use Fclts | $24,414 | DonatedServicesUseFcltsAmt |
| Other Expenses Included | -$572,738 | OtherExpensesIncludedAmt |
| Expenses Not Reported | -$548,324 | ExpensesNotReportedAmt |
| Expenses Subtotal | $16,939,060 | ExpensesSubtotalAmt |
| Total Expenses Per Form990 | $16,939,060 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| X 2 | The following was disclosed related to uncertain tax position in the audited financial statements. The American Diabetes Association Research Foundation, Inc. the Foundation is generally exempt from income taxes under section 501c3 of the Internal Revenue Code the Code and charitable contributions to the Foundation qualify for charitable tax deductions as described in the Code. The Foundation is subject to taxation on any net unrelated business income and has been classified as an organization that is not a private foundation under Section 509a of the Code. The Foundation recognizes the effect of income tax positions only if those positions more likely than not would not be sustained upon examination by the Internal Revenue Service. The Foundation has analyzed the tax positions taken and has concluded that as of December 31, 2021, there are no uncertain tax positions taken or expected to be take that would require recognition of a liability or asset or disclosure in the financial statements. |
| XII 2 | Prior Year Research Grants Awards/Forfeitures 572,738. |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (119 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|
| University of Connecticut School of Nursing | |||||||
| 231 Glenbrook Road | Storrs | CT | 06269 | 060772160 | 115 | $200,000 | Innovative Clinical or Translational Science New Health Disparities |
| University of Washington | |||||||
| 1201 Larimer Street | Seattle | WA | 99164 | 916001108 | 501c3 | $200,000 | Innovative Clinical or Translational Science New Health Disparities |
| The University of North Carolina at Chapel Hill | |||||||
| 104 Airport Dr Ste 2200 CD1350 | Chapel Hill | NC | 27157 | 223849199 | 501c3 | $199,993 | Innovative Clinical or Translational Science New Health Disparities |
| Kaiser Permanente Northern California | |||||||
| One Kaiser Plaza | Oakland | CA | 94612 | 941340523 | 501c3 | $199,977 | Innovative Clinical or Translational Science New Health Disparities |
| California Polytechnic State University | |||||||
| 1 Grand Avenue | San Luis Obispo | CA | 93407 | 204927897 | 501c3 | $190,000 | Innovative Clinical or Translational Science |
| Broad Institute Inc | |||||||
| 415 Main Street | Cambridge | MA | 02142 | 263428781 | 501c3 | $190,000 | Innovative Clinical or Translational Science |
| Stanford University | |||||||
| 3145 Porter Drive | Palo Alto | CA | 93407 | 204927897 | 501c3 | $190,000 | Innovative Clinical or Translational Science |
| University of Miami School of Medicine | |||||||
| PO Box 025405 | Miami | FL | 33102 | 590624458 | 501c3 | $190,000 | Innovative Clinical or Translational Science |
| Medical College of Wisconsin | |||||||
| 8701 Watertown Plank Rd | Milwaukee | WI | 53226 | 390806261 | 501c3 | $190,000 | Innovative Clinical or Translational Science |
| Arizona Board of Regents University of Arizona | |||||||
| 2700 N Central Ave Suite 850 | Phoenix | AZ | 85004 | 742652689 | 170c1 | $190,000 | Innovative Clinical or Translational Science |
| The Board Of Trustees Of The University Of Illinois | |||||||
| 506 S Wright Street 209 HAB NO MC33 | Urbana | IL | 61801 | 376000511 | 501c3 | $189,999 | Innovative Clinical or Translational Science |
| Benaroya Research Institute at Virginia Mason | |||||||
| 1201 Ninth Avenue | Seattle | WA | 98101 | 910653422 | 501c3 | $189,995 | Innovative Clinical or Translational Science |
| University of Utah | |||||||
| 201 South Presidents Circle Rm 406 | Salt Lake City | UT | 84112 | 876000525 | 501c3 | $186,708 | Innovative Clinical or Translational Science |
| George Washington University | |||||||
| 1922 F Street NW | Washington | DC | 20052 | 530196584 | 501c3 | $185,504 | Innovative Clinical or Translational Science New Health Disparities |
| The Board of Regents of the University of Wisconsin System | |||||||
| 21 N Park Street Suite 6401 | Madison | WI | 53226 | 390806261 | 501c3 | $184,325 | Innovative Clinical or Translational Science New Health Disparities |
| Ann and Robert H Lurie Children's Hospital of Chicago | |||||||
| 225 E Chicago Ave | Chicago | IL | 60611 | 362170833 | 501c3 | $175,593 | Innovative Clinical or Translational Science New Health Disparities |
| Case Western Reserve University | |||||||
| 10900 Euclid Avenue | Cleveland | OH | 45701 | 316402269 | 501c3 | $137,907 | Innovative Clinical or Translational Science New Health Disparities |
| Regents Of The University Of Michigan | |||||||
| 3003 S State St Rm 1054 | Ann Arbor | MI | 48202 | 386028429 | 501c3 | $131,100 | Junior Faculty |
| University of Iowa | |||||||
| 4 Jessup Hall Room B5 | Iowa City | IA | 52242 | 426004813 | 115 | $131,100 | Junior Faculty |
| Trustees of Indiana University | |||||||
| PO Box 500 | Bloomington | IN | 47402 | 356018940 | 501c3 | $131,100 | Junior Faculty |
| The Board of Trustees of the Leland Stanford Junior University | |||||||
| 450 Serra Mall | Stanford | CA | 941432212 | 680000845 | 501c3 | $131,100 | Junior Faculty Development |
| Duke University | |||||||
| 324 Blackwell St Washington Bldg | Durham | NC | 27599 | 566001393 | 501c3 | $131,100 | Junior Faculty Development |
| University of Pittsburgh School of Medicine | |||||||
| 116 Atwood Street Suite 201 | Pittsburgh | PA | 15261 | 250965591 | 501c3 | $131,100 | Junior Faculty Development |
| Ohio Department of Health Bureau of Maternal Child and Family Health | |||||||
| 246 N High Street 6th Floor | Columbus | OH | 43215 | 311334820 | 501a | $131,100 | Junior Faculty Development |
| City of Hope Beckman Research Institute | |||||||
| 1500 East Duarte Road | Duarte | CA | 94305 | 941156365 | 501c3 | $131,100 | Junior Faculty Development |
| Georgia State University Research Foundation Inc | |||||||
| 33 Gilmer Street SE | Atlanta | GA | 30303 | 581845423 | 501c3 | $131,100 | Junior Faculty Development |
| The University of North Carolina at Chapel Hill | |||||||
| 104 Airport Dr Ste 2200 CD1350 | Chapel Hill | NC | 27157 | 223849199 | 501c3 | $131,100 | Junior Faculty Development |
| University of Texas Southwestern Medical Center at Dallas | |||||||
| PO Box 841753 | Dallas | TX | 77840 | 742245072 | 501c3 | $131,100 | Junior Faculty Development |
| Texas A&M University System HSC | |||||||
| 401 George Bush Drive | College Station | TX | 77840 | 742245072 | 501c3 | $131,099 | Junior Faculty Development |
| Wayne State University School of Medicine | |||||||
| 5057 Woodward Avenue 13th floor Sui | Detroit | MI | 48202 | 386028429 | 501c3 | $131,095 | Junior Faculty Development |
| Medical College of Wisconsin | |||||||
| 8701 Watertown Plank Rd | Milwaukee | WI | 53226 | 390806261 | 501c3 | $130,317 | Junior Faculty Development |
| University Of Pittsburgh | |||||||
| 116 Atwood Street Suite 201 | Pittsburg | PA | 15261 | 250965591 | 501c3 | $127,558 | Junior Faculty Development |
| Colorado School of Mines | |||||||
| 1500 Illinois Street | Golden | CO | 80401 | 846000551 | 501c3 | $122,311 | Junior Faculty |
| Partners Healthcare System Inc | |||||||
| 399 Revolution Dr Ste 645 | Somerville | MA | 021451465 | 042103561 | 501c3 | $116,781 | Junior Faculty |
| The Regents of the University of California Los Angeles | |||||||
| 10920 Wilshire Blvd Ste 620 | Los Angeles | CA | 941432212 | 680000845 | 501c3 | $109,250 | Innovative Basic Science |
| Regents of the University of Minnesota | |||||||
| 450 McNamara Alumni Center | Minneapolis | MN | 55414 | 415007513 | 170c1 | $109,250 | Innovative Basic Science |
| Regents of the University of California | |||||||
| 1111 Franklin Street 10th Floor | Oakland | CA | 92093 | 956006144 | 501c3 | $109,250 | Innovative Basic Science |
| Yale University | |||||||
| 155 Whitney Avenue Room 230 PO Box | New Haven | CT | 06510 | 060646973 | 501c3 | $109,250 | Innovative Basic Science |
| Memorial Sloan Kettering Cancer Center | |||||||
| 1275 York Avenue | New York | NY | 10461 | 131624225 | 501c3 | $109,250 | Innovative Basic Science |
| The Ohio State University | |||||||
| 1960 Kenny Road | Columbus | OH | 45701 | 316402269 | 501c3 | $109,250 | Innovative Basic Science |
| The University of Texas Health Science Center at San Antonio | |||||||
| 7703 Floyd Curl Drive | San Antonio | TX | 77030 | 741613878 | 501c3 | $109,250 | Innovative Basic Science |
| Temple University of the Commonwealth System of Higher Education | |||||||
| 3333 N Broad Street | Philadelphia | PA | 15260 | 250965591 | 501c3 | $109,250 | Innovative Basic Science |
| Regents Of The University Of Michigan | |||||||
| 3003 S State St Rm 1054 | Ann Arbor | MI | 48202 | 386028429 | 501c3 | $109,250 | Innovative Basic Science |
| Louisiana State University Health Sciences Center New Orleans | |||||||
| 433 Bolivar Street | New Orleans | LA | 70112 | 726087770 | 501c3 | $109,250 | Innovative Basic Science |
| Universidad Central del Caribe | |||||||
| PO Box 60327 | Bayamon | PR | 00960 | 660349669 | 501c3 | $109,250 | Innovative Basic Science |
| University of Colorado at Boulder | |||||||
| 3100 Marine Street | Boulder | CO | 80208 | 840404231 | 501c3 | $109,250 | Innovative Basic Science |
| Vanderbilt University Medical Center | |||||||
| 3319 West End Avenue Ste 800 | Nashville | TN | 37203 | 620476822 | 501c3 | $109,250 | Innovative Basic Science |
| The University of Toledo Health Science Campus | |||||||
| 2801 West Bancroft Street | Toledo | OH | 44106 | 341018992 | 501c3 | $109,236 | Innovative Basic Science |
| Board of Regents of the University of Wisconsin System | |||||||
| 21 N Park Street Suite 6401 | Madison | WI | 53226 | 390806261 | 501c3 | $109,117 | Innovative Basic Science |
| University of Colorado Denver | |||||||
| 1800 Grant Street Suite 600 | Denver | CO | 80203 | 846000555 | 501c3 | $108,397 | Innovative Basic Science |
| Southern Illinois University School of Medicine | |||||||
| PO Box 19620 | Springfield | IL | 62794 | 376005961 | 501c3 | $108,012 | Innovative Basic Science |
| University of Washington | |||||||
| 1201 Larimer Street | Seattle | WA | 99164 | 916001108 | 501c3 | $98,055 | Innovative Basic Science |
| Children's Research Institute | |||||||
| 111 Michigan Ave NW | Washington | DC | 20010 | 521654453 | 501c3 | $68,608 | Postdoctoral Fellowship Health Disparities Award |
| Joslin Diabetes Center Inc | |||||||
| One Joslin Place | Boston | MA | 01655 | 043167352 | 115 | $67,743 | Mentor-Based Postdoctoral Fellowship |
| Baylor College of Medicine | |||||||
| One Baylor Plaza | Houston | TX | 75284 | 756002868 | 170c1 | $67,743 | Postdoctoral Fellowship |
| The Regents of the University of California San Francisco | |||||||
| 3333 California Street Ste 315 | San Francisco | CA | 910103012 | 953432210 | 501c3 | $67,743 | Postdoctoral Fellowship |
| University of Iowa | |||||||
| 4 Jessup Hall Room B5 | Iowa City | IA | 52242 | 426004813 | 115 | $67,743 | Minority Postdoctoral Fellowship PMF |
| University of Colorado | |||||||
| 1800 Grant Street Suite 600 | Denver | CO | 80203 | 846000555 | 501c3 | $67,500 | ADA-Pfizer Fellowship Award |
| University of Alabama at Birmingham | |||||||
| 1530 3rd Ave South AB 990 | Birmingham | AL | 35294 | 636005396 | 501c3 | $66,793 | Postdoctoral Fellowship |
| The Regents of the University of California | |||||||
| 2200 University Avenue | Berkeley | CA | 941432212 | 680000845 | 501c3 | $65,645 | Postdoctoral Fellowship |
| The Regents of the University of Michigan | |||||||
| 3003 South State Street | Ann Arbor | MI | 48109 | 386028429 | 501c3 | $65,645 | Postdoctoral Fellowship |
| Cincinnati Children's Hospital Medical Center | |||||||
| 3333 Burnet Avenue MLC 9002 | Cincinnati | OH | 43210 | 316025986 | 501c3 | $65,645 | Minority Postdoctoral Fellowship PMF |
| Cincinnati Children's Hospital Medical Center | |||||||
| 3333 Burnet Avenue MLC 9002 | Cincinnati | OH | 43210 | 316025986 | 501c3 | $65,553 | Postdoctoral Fellowship |
| The Regents of the University of Michigan | |||||||
| 3003 South State Street | Ann Arbor | MI | 48109 | 386028429 | 501c3 | $65,170 | Postdoctoral Fellowship |
| Partners Healthcare System Inc | |||||||
| 399 Revolution Dr Ste 645 | Somerville | MA | 021451465 | 042103561 | 501c3 | $64,144 | Postdoctoral Fellowship Health Disparities Award |
| Ann and Robert H Lurie Children's Hospital of Chicago | |||||||
| 225 E Chicago Ave | Chicago | IL | 60611 | 362170833 | 501c3 | $63,760 | Postdoctoral Fellowship Health Disparities Award |
| Beth Israel Deaconess Medical Center Inc | |||||||
| 330 Brookline Ave | Boston | MA | 02115 | 042774441 | 501c3 | $63,536 | Mentor-Based Postdoctoral Fellowship |
| The Rockefeller University | |||||||
| 1230 York Avenue | New York | NY | 10065 | 131924236 | 501c3 | $63,536 | Postdoctoral Fellowship |
| University of Michigan | |||||||
| 3003 S State St Rm 1054 | Ann Arbor | MI | 48202 | 386028429 | 501c3 | $63,536 | Postdoctoral Fellowship |
| University Of Pittsburgh | |||||||
| 116 Atwood Street Suite 201 | Pittsburg | PA | 15261 | 250965591 | 501c3 | $63,536 | Postdoctoral Fellowship |
| The Board of Trustees of the University of Illinois | |||||||
| 506 S Wright Street 209 HAB NO MC33 | Urbana | IL | 61801 | 376000511 | 501c3 | $63,536 | Postdoctoral Fellowship |
| Beth Israel Deaconess Medical Center Inc | |||||||
| 330 Brookline Ave | Boston | MA | 02115 | 042774441 | 501c3 | $63,536 | Minority Postdoctoral Fellowship PMF |
| Trustees of Columbia University in the City of New York | |||||||
| 615 West 131st Street MC 8741 | New York | NY | 10065 | 131924236 | 501c3 | $63,536 | Minority Postdoctoral Fellowship PMF |
| Sanford Burnham Prebys Medical Discovery Institute | |||||||
| 10901 North Torrey Pines Road | La Jolla | CA | 92037 | 952160097 | 501c3 | $61,518 | Postdoctoral Fellowship |
| Harvard Medical School | |||||||
| 1033 Massachusetts Ave Third Floor | Cambridge | MA | 01655 | 043167352 | 115 | $61,518 | Mentor-Based Postdoctoral Fellowship |
| Washington University | |||||||
| 700 Rosedale Avenue | Saint Louis | MO | 631121408 | 430653611 | 501c3 | $61,518 | Mentor-Based Postdoctoral Fellowship |
| University of Michigan | |||||||
| 3003 S State St Rm 1054 | Ann Arbor | MI | 48202 | 386028429 | 501c3 | $61,518 | Mentor-Based Minority Postdoctoral Fellowship |
| Adventist Health SystemSunbelt Inc dba Florida Hospital | |||||||
| 900 Hope Way | Altamonte Springs | FL | 33102 | 590624458 | 501c3 | $61,518 | Postdoctoral Fellowship |
| The Regents of the University of California Los Angeles | |||||||
| 10920 Wilshire Blvd Ste 620 | Los Angeles | CA | 941432212 | 680000845 | 501c3 | $61,518 | Postdoctoral Fellowship |
| University of Michigan | |||||||
| 3003 S State St Rm 1054 | Ann Arbor | MI | 48202 | 386028429 | 501c3 | $61,518 | Postdoctoral Fellowship |
| University of Iowa | |||||||
| 4 Jessup Hall Room B5 | Iowa City | IA | 52242 | 426004813 | 115 | $61,518 | Postdoctoral Fellowship |
| The Children's Hospital of Philadelphia | |||||||
| 3401 Civic Center Blvd | Philadelphia | PA | 19104 | 231352685 | 501c3 | $61,518 | Postdoctoral Fellowship |
| President and Fellows of Harvard College | |||||||
| 1033 Massachusetts Ave Third Floor | Cambridge | MA | 01655 | 043167352 | 115 | $61,518 | Minority Postdoctoral Fellowship PMF |
| University of Massachusetts | |||||||
| 333 South St Ste 450 | Shrewsbury | MA | 02115 | 042774441 | 501c3 | $61,518 | Minority Postdoctoral Fellowship PMF |
| University of Washington | |||||||
| 1201 Larimer Street | Seattle | WA | 99164 | 916001108 | 501c3 | $60,567 | Postdoctoral Fellowship |
| University of Texas Southwestern Medical Center at Dallas | |||||||
| PO Box 841753 | Dallas | TX | 77840 | 742245072 | 501c3 | $59,751 | Mentor-Based Postdoctoral Fellowship |
| Duke University | |||||||
| 324 Blackwell St Washington Bldg | Durham | NC | 27599 | 566001393 | 501c3 | $59,751 | Postdoctoral Fellowship |
| The University of Texas Health Science Center at San Antonio | |||||||
| 7703 Floyd Curl Drive | San Antonio | TX | 77030 | 741613878 | 501c3 | $59,751 | Minority Postdoctoral Fellowship PMF |
| Trustees of Columbia University in the City of New York | |||||||
| 615 West 131st Street MC 8741 | New York | NY | 10065 | 131924236 | 501c3 | $57,722 | Mentor-Based Minority Postdoctoral Fellowship |
| Joslin Diabetes Center Inc | |||||||
| One Joslin Place | Boston | MA | 01655 | 043167352 | 115 | $57,357 | Mentor-Based Postdoctoral Fellowship |
| Board of Regents of the University of Wisconsin System | |||||||
| 21 N Park Street Suite 6401 | Madison | WI | 53226 | 390806261 | 501c3 | $57,357 | Mentor-Based Postdoctoral Fellowship |
| Duke University | |||||||
| 324 Blackwell St Washington Bldg | Durham | NC | 27599 | 566001393 | 501c3 | $50,760 | ADA-Pfizer Fellowship Award |
| Partners Healthcare System Inc | |||||||
| 399 Revolution Dr Ste 645 | Somerville | MA | 021451465 | 042103561 | 501c3 | $49,283 | Postdoctoral Fellowship |
| Rector & Visitors of The University Of Virginia | |||||||
| 1001 North Emmet Street | Charlottesville | VA | 22904 | 546001796 | 501c3 | $36,100 | Innovative Basic Science |
| George Washington University Biostatistics Center | |||||||
| 6110 Executive Blvd | Rockville | MD | 20852 | 530196584 | 501c3 | $33,000 | RISE Federal Co-Support Award |
| Partners Healthcare System Inc | |||||||
| 399 Revolution Dr Ste 645 | Somerville | MA | 021451465 | 042103561 | 501c3 | $13,434 | Junior Faculty |
| Medical College of Wisconsin | |||||||
| 8701 Watertown Plank Rd | Milwaukee | WI | 53226 | 390806261 | 501c3 | $9,000 | Student Loan |
| The University of North Carolina at Chapel Hill | |||||||
| 104 Airport Dr Ste 2200 CD1350 | Chapel Hill | NC | 27157 | 223849199 | 501c3 | $9,000 | Student Loan |
| The Rockefeller University | |||||||
| 1230 York Avenue | New York | NY | 10016 | 135562308 | 501c3 | $308,750 | Early Investigator Award |
| Icahn School of Medicine at Mount Sinai | |||||||
| One Gustav L Levy Place Box 3500 | New York | NY | 14850 | 150532082 | 501c3 | $308,750 | Early Investigator Award |
| Columbia University | |||||||
| 615 West 131st Street MC 8741 | New York | NY | 10065 | 131924236 | 501c3 | $308,750 | Early Investigator Award |
| Washington University | |||||||
| 700 Rosedale Avenue | Saint Louis | MO | 631121408 | 430653611 | 501c3 | $308,750 | Early Investigator Award |
| University of Notre Dame | |||||||
| 724 Grace Hall | Notre Dame | IN | 46556 | 350868188 | 501c3 | $308,750 | Early Investigator Award |
| Dana-Farber Cancer Institute | |||||||
| 450 Brookline Avenue | Boston | MA | 02215 | 042263040 | 501c3 | $308,750 | Early Investigator Award |
| Yale University | |||||||
| 155 Whitney Avenue Room 230 PO Box | New Haven | CT | 06510 | 060646973 | 501c3 | $308,750 | Investigator New to Diabetes Research Award |
| University of California Santa Barbara | |||||||
| 3227 Cheadle Hall 3rd floor | Santa Barbara | CA | 931062050 | 956006145 | 501c3 | $308,750 | Investigator New to Diabetes Research Award |
| Joan & Sanford I Weill Medical College of Cornell University | |||||||
| 1300 York Ave | New York | NY | 10065 | 150532082 | 501c3 | $308,750 | Investigator New to Diabetes Research Award |
| University of Illinois at Urbana-Champaign | |||||||
| 1305 West Green Street | Urbana | IL | 61801 | 376006007 | 501c3 | $308,750 | Investigator New to Diabetes Research Award |
| University of Pennsylvania | |||||||
| 3451 Walnut St P-221 Frankin Buildi | Philadelphia | PA | 19104 | 231352685 | 501c3 | $308,750 | Investigator New to Diabetes Research Award |
| University of California San Francisco | |||||||
| 3333 California Street Ste 315 | San Francisco | CA | 94143 | 946036493 | 501c3 | $308,750 | Investigator New to Diabetes Research Award |
| Joslin Diabetes Center | |||||||
| One Joslin Place | Boston | MA | 02215 | 042203836 | 501c3 | $308,750 | Research Career Initiator |
| Indiana University | |||||||
| 107 S Indiana Avenue | Bloomington | IN | 47405 | 356001673 | 501c3 | $308,750 | Research Career Initiator |
| Jackson Laboratory | |||||||
| 600 Main Street | Bar Harbor | ME | 04609 | 010211513 | 501c3 | $308,548 | Early Investigator Award |
| Children's Research Institute | |||||||
| 111 Michigan Ave NW | Washington | DC | 20010 | 521654453 | 501c3 | $302,571 | Early Investigator Award |
| Stanford University | |||||||
| 3145 Porter Drive | Palo Alto | CA | 94305 | 941156365 | 501c3 | $300,722 | Research Career Initiator |
| Cedars-Sinai Medical Center | |||||||
| 8700 Beverly Blvd | West Hollywood | CA | 90048 | 951644600 | 501c3 | $295,826 | Research Career Initiator |
| University of Virginia | |||||||
| 1001 N Emmet St | Charlottesville | VA | 22904 | 546001796 | 501c3 | $289,750 | Research Career Initiator |
| Duke University | |||||||
| 324 Blackwell St Washington Bldg | Durham | NC | 27701 | 560532129 | 501c3 | $286,969 | Research Career Initiator |
| University of California San Diego | |||||||
| 9500 Gilman Drive 0954 | La Jolla | CA | 92093 | 956006144 | 501c3 | $218,140 | Research Career Initiator |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 119 | Total501c3OrgCnt |
Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Type | Junior Faculty Stipend Award | GrantTypeTxt |
| Recipient | 2 | RecipientCnt |
| Cash Grant | $18,000 | CashGrantAmt |
| Non Cash Assistance | N/A | NonCashAssistanceDesc |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Part I Line 2 | The American Diabetes Association Research Foundation closely monitors the use of grant funds. Each grantee is required to submit an Annual Progress Report, which includes a scientific and a financial portion, 30 days after the end of each previously committed funding year. Each year of funding after the first is contingent upon approval of the Annual Progress Report and the availability of funds. If the complete report is not received within 90 days after the due date, the award will be terminated. After the completion of the final year of the grant, a Cumulative Final Report, which includes a scientific and financial report, is due within 60 days after the expiration date of the grant. If the complete final report is not received by the due date, the grantee will not be eligible for any future awards until the obligations for the award are complete. |
| Part II | Core awards fall into three primary program types general research awards, career development awards, and training awards. Research awards are designed to support different types of research projects, career development awards are designed to assist young investigators and junior faculty advance in their careers as they establish independence from their mentors, and training awards offer support for post-doctoral fellows as they gain research training experience. Targeted awards are offered periodically as we secure sponsor support, and are usually designed to request research proposals in specific topics. These are usually one time offerings that are not offered again. Overall, the core awards will consider any research topic, but targeted awards are focused on specific fields of research. Pathway awards fall into three main categories Initiator, Accelerator, and Visionary. Our Pathway grants support innovative basic, clinical, translational, epidemiological, behavioral, or health services research relevant to any diabetes type, diabetes-related disease state, or diabetes complication. The Association seeks exceptional candidates from a broad range of disciplines, including medicine, biology, chemistry, computing, physics, mathematics and engineering. All Pathway awards are available by institutional nomination only. |
| Part III Line 1,2 | The American Diabetes Association Research Foundation program provides support to undergraduate minority students and young scientists through Junior Faculty Stipend Awards and Minority Undergraduate Internships. The Foundations Junior Faculty Stipend Award is designed to support new faculty level investigators. The award supports an individuals salary and research project through an annual loan repayment. The Minority Undergraduate Internship award funds the training of an underrepresented minority undergraduate student as she/he gains valuable experience in diabetes research through a one year internship. |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Severance Payment | false | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (true) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | false | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (4 entries)
| TitleTitleTxt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|
| Robert A Gabbay | |||||||
| Chief Scientific Medical Officer and Office of the CEO | $453,597 | $3,614 | $23,539 | $18,850 | $499,600 | ||
| Charlotte M Carter | |||||||
| Chief Financial Officer and Office of the CEO | $321,749 | $2,266 | $19,875 | $9,662 | $353,552 | ||
| Tracey D Brown through October 6 20 | |||||||
| Chief Executive Officer | $467,199 | $373,708 | $116,123 | $22,452 | $1,186,496 | $207,014 | $348,133 |
| Charles D Henderson | |||||||
| Chief Development Officer and Office of the CEO | $293,056 | $1,282 | $15,295 | $1,013 | $310,646 | ||
Supplemental Information Detail SupplementalInformationDetail (5 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Part I Line 3 | The Office of the Chief Executive Officer, the Chief Financial Officer, the Chief Development Officer and the Chief Scientific Medical Officer of the American Diabetes Association the Association also serve in these roles for the American Diabetes Association Research Foundation the Foundation. The Principal Officers of the Board of Directors of the Association use an executive compensation committee, compensation studies, and an independent consultant to establish the compensation of the Chief Executive Officer. The Committee also reviews the compensation of the other staff to ensure compensation is within the guidelines set by the Committee. |
| Part I Line 4b | Tracey D. Brown, Chief Executive Officer, is compensated by the American Diabetes Association and contributed 95,823 to its supplemental 457f retirement plan. |
| Part I Line 4b | Robert Gabbay, Chief Scientific and Medical Officer, is compensated by the American Diabetes Association and contributed 16,733 to its supplemental 457f retirement plan. |
| Part I Line 4b | Charlotte M. Carter, Chief Financial Officer, is compensated by the American Diabetes Association and contributed 8,713 to its supplemental 457f retirement plan. |
| Part I Line 4b | Charles D. Henderson, Chief Development Officer, is compensated by the American Diabetes Association and contributed 7,747 to its supplemental 457f retirement plan. |
Schedule L IRS990ScheduleL
Grnt Asst Bnft Interested Prsn GrntAsstBnftInterestedPrsnGrp (2 entries)
| Relationship With OrgRelationshipWithOrgTxt | Cash GrantCashGrantAmt | Assistance PurposeAssistancePurposeTxt |
|---|---|---|
| Rebekah J Walker PhD | ||
| Grant Review Committee Member | $130,317 | Junior Faculty Development |
| Rebekah J Walker PhD | ||
| Grant Review Committee Member | $9,000 | Student Loan |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Part III Line 1 | FormAndLineReferenceDesc |
| Explanation | The Scientific Review Panel follows the requirements of the American Diabetes Associations conflict of interest policy when reviewing grant applications and providing funding recommendations. Members must recuse themselves for institutional, financial, and personal conflicts of interest. Panel members are not permitted to participate in the grant review process if they are listed as the principal investigator of an application under consideration. In addition, members may not participate in the review of a specific grant if the principal investigator is a close collaborator or close associate of the panel member. | ExplanationTxt |
Schedule N IRS990ScheduleN
Liquidation Of Assets Table LiquidationOfAssetsTableGrp
Liquidation Of Assets Detail LiquidationOfAssetsDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Assets Distri Or Expnss Paid | Cash and receivables | AssetsDistriOrExpnssPaidDesc |
| Distribution | 2021-12-31 | DistributionDt |
| Fair Market Value Of Asset | $8,403,794 | FairMarketValueOfAssetAmt |
| Method Of FMV Determination | Book Value | MethodOfFMVDeterminationTxt |
| EIN | 131623888 | EIN |
| Person | American Diabetes Association | PersonNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2451 Crystal Drive Suite 900 | AddressLine1Txt |
| City | Arlington | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22202 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRC Section | 501c3 | IRCSectionTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Director Of Successor | Yes (true) | DirectorOfSuccessorInd |
| Employee Of Successor | Yes (true) | EmployeeOfSuccessorInd |
| Owner Of Successor | false | OwnerOfSuccessorInd |
| Receive Compensation | false | ReceiveCompensationInd |
| Assets Distributed | Yes (true) | AssetsDistributedInd |
| Required To Notify AG | Yes (true) | RequiredToNotifyAGInd |
| Attorney General Notified | Yes (true) | AttorneyGeneralNotifiedInd |
| Liabilities Paid | Yes (true) | LiabilitiesPaidInd |
| Bonds Outstanding | false | BondsOutstandingInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Part I Line 2a, 2b | FormAndLineReferenceDesc |
| Explanation | The board of directors of the American Diabetes Association Research Foundation, Inc. was composed entirely of members of the board of directors of the American Diabetes Association as of December 31, 2021. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (36 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Form 990, Part I, Line 1 | The American Diabetes Association Research Foundation, Inc. the Foundation secures major gifts and grants to fund diabetes-related research. |
| Form 990, Part VI, Section A, Line 1a | The main responsibilities and focus of the Foundations Board is to advance, support and promote charitable contributions by soliciting major gifts for the purpose of funding the American Diabetes Associations nationwide Research Program. The Board of Directors of the Foundation provides governance over the activities of the Foundation in accodance with the purposes, policies and procedures of the American Diabetes Association. The Board delegates to the Foundations Executive Committee responsibililty for management of the Foundation when the Board is not in session. The American Diabetes Association provides complete operational support to the Foundation including staff, facilities and administrative processes. The Foundations annual budget and audit process are governed by the American Diabetes Association Board of Directors and Audit Committee. |
| Form 990, Part VI, Section A, Line 3,7a,7b | The Foundations affairs are managed by the Foundation Board of Directors. The Board of Directors of the Foundation supervises, directs and controls the activities of the Foundation in accordance with the mission, purposes, policies and procedures of the American Diabetes Association. The Board delegates to the Foundations Executive Committee responsibility for management of the Foundation when the Board is in session. The American Diabetes Association provides complete operational support to the Foundation including staff, facilities and administrative processes. The Foundations annual budget and audit process are governed by the American Diabetes Association Board of Directors and Audit Committee. If a vacancy occurs among the Foundations officers for any reason, the Board of Directors of the American Diabetes Association shall fill such position for the unexpired portion of the term. |
| Form 990, Part VI, Section B, Line 11b | IRS Form 990 Review Process by the Governing Body The American Diabetes Association Research Foundation the Foundation draft IRS 990 is reviewed by the American Diabetes Associations management and BDO. The final and signed IRS Form 990 was provided to the Associations Board of Directors and the Foundations Board of Directors prior to filing with the IRS. |
| Form 990, Part VI, Section B, Line 12c | Managing a Conflict of Interest To identify potential conflicts of interest with appropriate due dilligence, the Foundations Officers, Directors and Members of the Grant Review Panel must annually disclose any potential conflicts of interest. The American Diabetes Associations Audit Committee and senior staff in Legal Affairs manage the disclosure and monitoring processes of the Board. The senior staff of the Associations Scientific Medical Division manage the disclosure and monitoring processes of the Grant Review Panel. Through review of the annual disclosure and review of the agendas of relevant Board, Committee and other meetings, appropriate efforts are made in advance of the meetings to identify potential conflicts of interest. Each person also has the responsibility to report his/her own conflicts of interest actual or perceived as those conflicts may arise during a meeting. |
| Form 990, Part VI, Section B, Line 12c | Research Grants Review Committee Conflict of Interest COI within the Research Grants Review Committee is managed through a written COI policy and through COI declarations signed both before and after the review cycle. The COI for grant reviewers is self-reported. The primary considerations addressed in the COI policy and program guidelines are as follows - Institutional Individuals are required to recuse themselves from reviewing grants for scientists at the same institution, including any institutions with which they may be negotiating employment. - Financial Individuals are required to recuse themselves from reviewing grants from which they stand to gain financially if the grant is awarded co-PI, collaborator, subcontracts, etc.. - Personal Individuals are required to recuse themselves from reviewing grants for investigators with whom they either have a personal or professional relationship collaborators, colleagues or personal friends, or a long standing professional or scientific disagreement that prevents them from unbiased review. |
| Form 990, Part VI, Section B, Line 13 | The American Diabetes Association has a written whistleblower policy that applies to the American Diabetes Association Research Foundation. |
| Form 990, Part VI, Section C, Line 17 | Alabama AL97-256 Alaska N/A Arizona10145 Arkansas N/A California CT81471 Colorado 2002-3003670 Connecticut CHR.0005084 Delaware N/A District of Columbia 981855 Florida CH1618 GeorgiaCH-001422 Hawaii N/A Idaho N/A Illinois CO01-025537 Indiana103829 Iowa N/A Kansas 177-257-350 Kentucky ID 45 Louisiana 34629813X Maine CO-1247 Maryland 102 Massachusetts Attorney General 029317 Michigan MICS 10326 Minnesota N/A Mississippi 100000294 Missouri CO- 021-87 Montana N/A Nebraska N/A Nevada N/A New Hampshire 5006New Jersey CH-0581900 New Mexico 1936418 New York 01-30-65 North Carolina SL000618 North Dakota 7894 Ohio 01-0239 Oklahoma 29417396 Oregon16402 Pennsylvania 21 Rhode Island 9500233 South Carolina 641South Dakota N/A Tennessee CO1919 Texas N/A Utah 6536093-CHAR Vermont N/A Virginia N/A Washington 1100167 West Virginia N/A Wisconsin3020-800 WyomingN/A |
| Form 990, Part VI, Section B, Line 14 | The American Diabetes Association has a written Document Retention and Destruction policy that applies to the American Diabetes Research Foundation. |
| Form 990, Part VI, Section C, Line 19 | Document Disclosure The following Research Foundation documents are not available on the American Diabetes Association website http//www.diabetes.org but are available upon written request to the American Diabetes Association Legal Affairs Department Board of Directors, audited financial statements, IRS Form 990, whistleblower policy, current bylaws, articles of incorporation and conflict of interest policy. |
| Form 990, Part VII, Section A, Line 1,2,3 | The Chief Executive Officer is a non-voting member of the Research Foundation Board of Directors. The Chief Executive Officer, the Chief Financial Officer, the Chief Development Officer and the Chief Scientific Medical Officer are compensated by the American Diabetes Association based on a standard average of 37.5 hours per week. |
| Form 990, Part VII, Section A, Line 2,4 | Tracey D. Brown ended her tenure as Chief Executive Officer on October 6, 2021. On that day, the Chief Financial Officer, Chief Development Officer and Chief Scientific and Medical Officer were appointed to the Office of the CEO by the Associations Board of Directors. |
| Form 990, Part XI, Line 9 | Other changes in net assets or fund balances of 572,737 reflect prior year research grant award refunds and forfeitures. Net assets were adjusted by 8,403,794 for the merger of ADA Research Foundation, Inc. into the American Diabetes Association as of December 31, 2021. |
| Form 990, Part VI, Section A, Line 2 | Pearson C. Cummin, III, Secretary-Treasurer, and Linda Cummin, Board of Directors, have a family relationship. |
| Form 990, Part III, Line 4 | Connected for Life |
| Form 990, Part III, Line 4 | Today, more than 133 million Americans in the United States have diabetes or prediabetes an invasive, unrelenting, and debilitating disease that spans all ages, geographic areas, and educational levels. This chronic disease targets children, the elderly, and minority populations more than others and costs the United States 327 billion each year in lost productivity. It is a global epidemic that contributes to heart disease, stroke, nerve and kidney disease, and vision loss. The American Diabetes Association ADA is the only organization dedicated specifically to the research, education, and advocacy required to improve the lives of the 37.3 million adults and children in the U.S. with diabetes and the 96 million people with prediabetes. For 81 years, we have been working on the front lines to educate at-risk populations protect the rights of people with diabetes at work, school, and other aspects of daily life pioneer clinical and research breakthroughs and foster a pipeline of the best and brightest scientists. |
| Form 990, Part III, Line 4 | The COVID-19 pandemic shined a very bright spotlight on diabetes as a public health crisis and on severe health inequities in our country. For people with diabetes, COVID-19 poses a much greater threat of severe complications, hospitalization, and even death. The ADA quickly adapted our resources, programs, and events in service to people living with diabetes and the health care professionals who treat them, and in 2021 we remained focused on ensuring people with diabetes could continue to get the care they needed to stay healthy and thrive.From research labs to the halls of the Capitol to the offices of health care practitioners to communities nationwide, the ADA is there. We are bending the curve to help people living with diabetes and their families thrive. Why Because we envision a life free of diabetes and all its burdens, which is fueled by our mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. |
| Form 990, Part III, Line 4 | DIABETES RESEARCH |
| Form 990, Part III, Line 4 | Diabetes is an extremely complex disease, caused by a combination of various genetic and environmental factors that progressively lead to an inability to produce or effectively use insulin. The complexity of causes conspiring to diminish the bodys production or response to insulin, leading to high blood glucose blood sugar and eventual development of diabetes, makes finding a single cure particularly difficult. While a cure has been elusive, critical research efforts in recent decades have led to significantly improved patient care, resulting in fewer complications and better health outcomes for individuals with diabetes. |
| Form 990, Part III, Line 4 | As the only organization dedicated specifically to the research, education, and advocacy required to improve the lives of all people with diabetes, the ADA funds critical, innovative diabetes research and invests in promising scientists early in their careers. Our leadership in diabetes research extends back to the 1940s when Dr. Charles H. Best, one of four scientists credited with discovering insulin, provided the ADA with the framework and early leadership for a formalized diabetes research program. |
| Form 990, Part III, Line 4 | Since the ADA started its Research Programs in 1952, we have invested nearly 900 million in more than 4,850 diabetes research projects. In 2021 alone, we supported over 250 research projects at 123 leading research institutions across the U.S., all dedicated to progressing the fight against diabetes. Of these projects, 96 were led by in-training or early-career investigators. |
| Form 990, Part III, Line 4 | While we have learned much about diabetes, there is so much left to discover. The primary goals of the ADAs Research Program are to Support the highest-quality science across the broad spectrum of diabetes research. Support investigators early in their careers to encourage them to dedicate their efforts to diabetes research. Support innovative research with a high potential to have a significant impact for patients with diabetes. |
| Form 990, Part III, Line 4 | Peer Review Process. One of the factors that sets ADA funded research apart and ensures that we are supporting the very best science is peer review. Peer review is a process whereby grant applications are reviewed and evaluated by individuals who are experts in the field or peers of the individual submitting the grant. ADA grant applications undergo peer review by three or more volunteer experts who are themselves experienced researchers. Reviewers provide both a score and detailed comments regarding the strengths and weaknesses of each grant they review. Scores from all reviewers for each grant are averaged to arrive at a composite merit score that is then used to determine which grants to support. |
| Form 990, Part III, Line 4 | 2021 Research Approach. The ADAs research strategy is targeted and laser focused, an approach that allows us to respond swiftly and decisively to the pressing needs of the diabetes community. For 2021 we prioritized action oriented research around health disparities, awarding funds to 11 projects including research on engaging grandmothers in care, using texting to improve diabetes management among people experiencing homelessness, and culinary education as a means for diabetes education. While we have a targeted approach to funding, we are also continuing to invest in our many career and training awards. Investing in early career diabetes professionals allows us to uplift, support, mentor, and secure the next generation of researchers as they prepare to care for the millions living with diabetes and prediabetes. |
| Form 990, Part III, Line 4 | COVID-19 ResearchIn 2021 the ADA saw the first results of the 1 million we invested in 2020 to investigate the link between the coronavirus and diabetes. These 10 research projects began to paint a clearer picture of why people with obesity and diabetes are at higher risk for hospitalization, serious outcomes, and death from the virus. |
| Form 990, Part III, Line 4 | Heres some of what weve learned about diabetes and COVID19 |
| Form 990, Part III, Line 4 | The coronavirus can infect and damage insulin-producing beta cells, causing them to produce significantly less insulin and more glucagon. This could account for higher rates of diabetes diagnoses among people infected with COVID19. Dr. Shuibing Chen, Weill Cornell Medicine |
| Form 990, Part III, Line 4 | When delivered to the nose and throat of an animal model, the coronavirus could later be found in the beta cells of the pancreas. These beta cells appeared to show the hallmarks of stress seen in the pancreases of people with type 2 diabetes. Dr. Senta Georgia, Childrens Hospital Los Angeles |
| Form 990, Part III, Line 4 | Individuals with metabolic syndrome of which diabetes is one factor were 3.4 times more likely to die from COVID19 and nearly 5 times more likely to be admitted to an ICU, need a ventilator, or develop acute respiratory distress syndrome. These findings suggest that the underlying inflammation seen with metabolic syndrome may be the driver that leads to more severe cases of COVID19. Dr. Joshua Denson, Tulane University |
| Form 990, Part III, Line 4 | In a laboratory setting, the coronavirus can directly infect fat and associated immune cells, eliciting a dramatic inflammatory response. This work tells us that the more fat cells a person has, the more of a reservoir the virus has to multiply, which could explain why people with obesity are at higher risk of severe illness and death from COVID19. Dr. Tracey McLaughlin, Stanford University |
| Form 990, Part III, Line 4 | While we have much more work ahead of us, these findings have opened important new avenues of research and helped identify potential therapeutic strategies which could ultimately reduce the burden of COVID19 in people with obesity and diabetes. |
| Form 990, Part III, Line 4 | Scientific SessionsHeld annually, Scientific Sessions exemplifies the ADAs leadership role in the global diabetes community while providing a critical platform for driving diabetes awareness. Scientific Sessions is the worlds largest scientific and medical meeting focused on the latest basic and clinical science research related to diabetes and its complications. |
| Form 990, Part III, Line 4 | For the second time in a row, the ADA conducted the five day conference completely online due to the COVID19 pandemic. Whether future meetings are in person, virtual, or hybrid, the Scientific Sessions remains a place for scientists to share their latest research findings, for physicians to learn how to best treat patients with diabetes, and for diabetes educators to exchange best practices for helping people manage the disease. The virtual 81th Scientific Sessions by the numbers 11,685 total attendees, 119 countries represented, 191 educational sessions, 850 presenters, 1,489 published abstracts, 1,098 eposter presentations |
| Form 990, Part III, Line 4 | Were Connected for Life. The American Diabetes Association is the nations leading voluntary health organization fighting to bend the curve on the diabetes epidemic to help people live a better life and thrive until we ultimately find a cure. The moving force behind the work of the American Diabetes Association is a network of more than 565,000 volunteers, their families and caregivers, a professional society of nearly 16,000 health care professionals, as well as more than 250 staff members. |
| Form 990, Part III, Line 4 | Diabetes has brought us all together, what we do next makes us Connected for Life. Learn more about the American Diabetes Association at diabetes.org. |
| Form 990, Part III, Line 3 | On December 31, 2021, the American Diabetes Association Research Foundation, Inc. merged into the American Diabetes Association and has therefore ceased making research grants. The research grant program will be continued by the American Diabetes Association. |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (2 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Direct Controlling NADirectControllingNACd | Controlled OrganizationControlledOrganizationInd | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt |
|---|---|---|---|---|---|---|---|---|---|---|---|
| American Diabetes Association | |||||||||||
| 2451 Crystal Drive Suite 900 | Arlington | VA | 22202 | 131623888 | See Part VII | OH | 501 c 3 | 7 | N/A | false | |
| American Diabetes Association Property Title Holding Corporation | |||||||||||
| 2451 Crystal Drive Suite 900 | Arlington | VA | 22202 | 541948004 | See Part VII | VA | 501 c 2 | N/A | false | Association | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (true) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | false | DivRelatedOrganizationInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | false | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | Yes (true) | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (true) | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (true) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | false | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | false | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | Yes (true) | TransferToOtherOrgInd |
| Transfer From Other Org | false | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (2 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| American Diabetes Association | ||
| c | $6,220,482 | Contribution determined by management |
| American Diabetes Association | ||
| r | $8,403,794 | Net asset value |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Part II Line 1b | The mission of the American Diabetes Association is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. |
| Part II Line 2b | The American Diabetes Association Property Title Holding Corporation was established to hold title to real property, collect the income therefrom, and remit to the American Diabetes Association. |
Affiliate Listing AffiliateListing
Affiliate Listing AffiliateListingGrp
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | American Diabetes Association Research Foundation Inc | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2451 Crystal Drive Suite 900 | AddressLine1Txt |
| City | Arlington | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22202 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 541734511 | EIN |
| Business Name Control | AMER | BusinessNameControlTxt |